Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Healthcare Industry News GE HealthCare’s $2.3bn Intelerad acquisition boosts SaaS ambitions and lifts investor sentiment GE HealthCare to acquire Intelerad for $2.3B to scale SaaS imaging across care settings. Explore what this means for investors and the AI roadmap. byVenkateshNovember 21, 2025